Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

27 August 2022 (08:15 - 09:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Steven Hageman

University Medical Center Utrecht, Utrecht (Netherlands (The))

7 More presentations in this session

Presentation thumbnail

Potential impact of replacing SCORE with SCORE-2 on risk classification and statin eligibility - a coronary calcium score correlation study

Miss M. Paiva (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Associations of SCORE2, circulating cardiovascular biomarkers and carotid intima-media-thickness in a population-based cohort

Doctor B. Toprak (Hamburg, DE)

Abstract Slides

Presentation thumbnail

Comparison between the European SCORE and the updated SCORE2 for cardiovascular outcomes

Doctor M. Temtem (Funchal, PT)

Abstract Slides

Presentation thumbnail

Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals

Doctor A. Yari (Stockholm, SE)

Abstract Slides

Presentation thumbnail

In a large dataset of primary care patients, use of CHA2DS2-VA score leads to almost universal recommendation for anticoagulation in those aged 65 years and over with atrial fibrillation

Doctor J. Orchard (Sydney, AU)

Abstract Slides

Access the full session

Session thumbnail

Cardiovascular risk assessment and scores

The Event

Event poster

ESC Congress 2022

27 August 2022 08:15 CET

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Webinar

Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources